Tumor volumes were slightly lower in the treated group (Online Resource 2a) and, most importantly, survival of treated animals was somewhat higher than controls (Online Resource 2b), suggesting IL-6 inhibition and impairment of DS-1 cell proliferation. Here, MRPL58 is linked to neoplasm.